GO:0001740 Barr body: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• The Barr body is a densely heterochromatic, transcriptionally silenced X chromosome located at the nuclear periphery in female mammalian cells.
• It is formed by X-chromosome inactivation, a process that balances X-linked gene dosage between XX females and XY males.
• The Barr body is enriched in heterochromatin marks such as H3K27me3 and H2AK119ub, and coated by the long non-coding RNA XIST.
• Loss or disruption of the Barr body is observed in several cancers, including breast, ovarian, and head and neck cancers.
• Barr body status can be assessed in clinical cytology and histology, and its disappearance may serve as a tumor marker.
• CRISPR-based models (knockout, knock-in, overexpression) enable functional dissection of genes controlling Barr body formation and maintenance.
Description
The Barr body (GO:0001740) is a cytologically distinct structure found in the nucleus of female mammalian cells, representing an entire X chromosome that has undergone inactivation. First described by Murray Barr in 1949, it is a classic example of epigenetic silencing and nuclear organization. The Barr body is not merely a passive storage form of the inactive X; it actively contributes to gene dosage compensation and its integrity is linked to cellular differentiation and disease. In this article, we provide a comprehensive overview of the Barr body, covering its definition, composition, assembly, associated genes, regulatory mechanisms, disease relevance, and modern research methods including CRISPR-based approaches. This resource is designed for researchers, clinicians, and students seeking authoritative, citable information on GO:0001740.
Barr body At A Glance
| GO ID | GO:0001740 |
|---|---|
| GO term | Barr body |
| Ontology | cellular_component |
| Synonym | None |
| Major function | Dosage compensation via transcriptional silencing of one X chromosome in female mammals |
| Location | Nuclear periphery |
| Composition | Heterochromatin enriched in H3K27me3, H2AK119ub, XIST RNA, and associated proteins |
| Formation | Established during early embryogenesis by X-chromosome inactivation |
| Clinical relevance | Loss or alteration in breast, ovarian, and head and neck cancers |
What Is GO:0001740?
According to the Gene Ontology, the Barr body is a structure found in a female mammalian cell containing an unpaired X chromosome that has become densely heterochromatic, silenced and localized at the nuclear periphery. It is the cytological manifestation of X-chromosome inactivation, a dosage compensation mechanism ensuring that XX females and XY males express similar levels of X-linked genes.
Why Is Barr body Important in Cell Biology?
The Barr body is a fundamental example of epigenetic regulation and nuclear architecture, and its study has illuminated mechanisms of dosage compensation, heterochromatin formation, and non-coding RNA function. Clinically, the presence or absence of Barr bodies is used in cytogenetic diagnosis of sex chromosome abnormalities and is increasingly recognized as a marker in cancer pathology. Understanding the Barr body also provides insights into how cells maintain gene silencing and how this process can be disrupted in disease.
• Serves as a model for understanding X-chromosome inactivation and dosage compensation.
• Provides insight into heterochromatin formation and maintenance.
• Its presence is used in clinical cytology to determine sex and diagnose sex chromosome disorders.
• Loss of the Barr body is associated with breast and ovarian cancers.
• Disruption of Barr body integrity is observed in head and neck cancer.
• Heterochromatin instability involving the Barr body is linked to cancer progression.
• Barr body status can be a prognostic marker in ovarian malignancies.
• It is a target for epigenetic therapies aiming to reactivate silenced genes.
• Studying the Barr body informs nuclear organization and genome regulation.
• CRISPR screens can identify genes required for Barr body formation and maintenance.
Structure and Composition of Barr body
XIST RNA coating and recruitment
In simple terms: A special RNA molecule called XIST coats one X chromosome and starts the silencing process.
The long non-coding RNA XIST is expressed from the inactive X chromosome and physically coats it in cis, recruiting silencing factors that initiate heterochromatin formation. XIST RNA is essential for X-chromosome inactivation and remains associated with the Barr body.
Heterochromatin marks and proteins
In simple terms: Chemical tags on histone proteins lock the chromosome into a tightly packed, silent state.
The Barr body is enriched in repressive histone modifications, including H3K27me3 and H2AK119ub, which are deposited by Polycomb repressive complexes. These marks contribute to the dense, heterochromatic nature of the Barr body.
Nuclear periphery localization
In simple terms: The silenced X chromosome moves to the edge of the nucleus.
The Barr body is typically localized at the nuclear periphery, where it associates with the nuclear lamina. This peripheral positioning is thought to reinforce silencing and is a hallmark of the Barr body.
Dynamic assembly during development
In simple terms: The Barr body forms early in development and its structure changes over time.
X-chromosome inactivation is a multistep process that occurs during early embryogenesis, involving counting, choice, and initiation phases. The Barr body becomes increasingly heterochromatic and compact as development proceeds.
Key Genes Involved in GO:0001740 Barr body
The following genes and non-coding RNAs are key players in the formation, maintenance, and function of the Barr body.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XIST | Long non-coding RNA that coats the inactive X and initiates silencing | Central to X-inactivation; knockout abolishes Barr body formation |
| XACT | Long non-coding RNA that coats the active X and may antagonize XIST | Potential regulator of X-inactivation choice |
| TSIX | Antisense transcript of XIST that negatively regulates XIST | Controls XIST expression and choice of inactive X |
| EZH2 | Catalytic subunit of Polycomb repressive complex 2 (PRC2) | Deposits H3K27me3 on the inactive X; knockout affects heterochromatin |
| SUZ12 | Core subunit of PRC2 | Required for H3K27me3 and Barr body maintenance |
| EED | Core subunit of PRC2 | Essential for PRC2 function and X-inactivation |
| RNF2 | Catalytic subunit of Polycomb repressive complex 1 (PRC1) | Deposits H2AK119ub; involved in silencing |
| BMI1 | Component of PRC1 | Contributes to heterochromatin formation |
| SMCHD1 | Structural maintenance of chromosomes protein | Required for maintenance of X-inactivation and Barr body |
| HNRNPK | RNA-binding protein | Interacts with XIST and facilitates silencing |
| SPEN | RNA-binding transcriptional repressor | Binds XIST and recruits silencing complexes |
| WTAP | m6A RNA methyltransferase subunit | Regulates XIST RNA stability and function |
| METTL3 | m6A RNA methyltransferase | Modifies XIST RNA; affects X-inactivation |
| YY1 | Transcription factor | Binds XIST promoter and regulates its expression |
| CTCF | Chromatin insulator protein | May influence X-chromosome topology and inactivation |
| LBR | Lamin B receptor | Anchors heterochromatin to nuclear periphery |
| LMNA | Lamin A/C | Nuclear lamina protein; mutations affect nuclear organization |
| ATRX | Chromatin remodeler | Involved in heterochromatin maintenance; mutations linked to disease |
How Is Barr body Regulated?
The formation and maintenance of the Barr body are regulated by a complex interplay of non-coding RNAs, chromatin modifiers, and nuclear architectural proteins. XIST RNA expression is controlled by pluripotency factors and developmental signals, while its silencing function depends on recruitment of PRC2, PRC1, and other repressive complexes. Additionally, m6A modification of XIST RNA by METTL3/WTAP regulates its stability and interaction with silencing factors. The nuclear periphery and lamina proteins such as LBR and LMNA contribute to anchoring and stabilizing the Barr body.
Barr body and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| XIST | Breast and ovarian cancer; loss of X-inactivation | XIST knockout or overexpression in cancer cell lines |
| EZH2 | Cancer; heterochromatin instability | EZH2 knockout or point mutation in cell lines |
| SMCHD1 | Developmental disorders; X-inactivation defects | SMCHD1 knockout in female cells |
| ATRX | Neurodevelopmental disorders; heterochromatin defects | ATRX knockout or point mutation |
| LMNA | Laminopathies; nuclear organization defects | LMNA knockout or knock-in in fibroblasts |
Barr body loss in breast and ovarian cancers
The disappearance of the Barr body has been observed in breast and ovarian cancers, suggesting that loss of X-chromosome inactivation may contribute to tumorigenesis. In ovarian malignancies, Barr body frequency is often reduced, and this loss may serve as a diagnostic marker.
Barr body in head and neck cancer
Alterations in Barr body frequency have been reported in head and neck squamous cell carcinoma, where loss of the Barr body correlates with malignancy. This suggests that X-chromosome inactivation status may influence cancer development and progression.
Heterochromatin instability and cancer
Disruption of heterochromatin, including the Barr body, is a common feature of cancer cells and may lead to genomic instability. The Barr body serves as a model for understanding how heterochromatin instability contributes to cancer.
Clinical cytology and diagnosis
Barr body analysis in fine needle aspiration cytology and hair root cells has been used to assess sex and diagnose sex chromosome abnormalities. Its presence or absence can provide valuable diagnostic information.
From Barr body-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does XIST knockout abolish Barr body formation? | XIST knockout in female human or mouse cell lines |
| Does a point mutation in EZH2 affect H3K27me3 and Barr body? | EZH2 point-mutation knock-in cell lines |
| Can XIST overexpression induce Barr body in male cells? | XIST overexpression in male cell lines |
| Where is the Barr body located in the nucleus? | Tagged knock-in of nuclear lamina proteins (e.g., LMNA-GFP) |
| What genes are required for Barr body maintenance? | CRISPR library screening in female cells |
| Does loss of SMCHD1 disrupt Barr body? | SMCHD1 knockout in female fibroblasts |
How to Study the Barr body Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Giemsa staining | Presence of Barr body | Clinical cytology and sex determination |
| RNA FISH | XIST RNA localization | Visualization of inactive X and Barr body |
| ChIP-seq | Histone modifications (H3K27me3, H2AK119ub) | Mapping heterochromatin on inactive X |
| ATAC-seq | Chromatin accessibility | Assessing silenced state of Barr body |
| CRISPR knockout screen | Gene requirement for Barr body | Identifying novel regulators |
| Proteomics | Protein composition of Barr body | Identifying associated factors |
| Live-cell imaging | Dynamics of Barr body | Tracking XIST and chromatin in real time |
| Single-cell RNA-seq | Gene expression from inactive X | Measuring escape genes |
Cytological detection of Barr bodies
Barr bodies can be visualized in interphase nuclei using simple staining techniques such as Giemsa or Feulgen, and are typically seen as a darkly stained mass at the nuclear periphery. This method is widely used in clinical cytogenetics and cancer diagnostics.
RNA fluorescence in situ hybridization (FISH)
RNA FISH using probes against XIST RNA allows direct visualization of the inactive X chromosome and the Barr body in single cells. This technique is essential for studying XIST localization and Barr body formation.
Chromatin immunoprecipitation (ChIP) and sequencing
ChIP-seq for histone modifications such as H3K27me3 and H2AK119ub can map the epigenetic landscape of the Barr body. This provides genome-wide insights into heterochromatin formation.
CRISPR-based genetic screens
Pooled CRISPR knockout screens can identify genes required for Barr body formation and maintenance. Such screens have revealed novel regulators of X-chromosome inactivation.
How CRISPR Can Be Used to Study GO:0001740 Barr body
Knockout
CRISPR knockout of XIST or chromatin modifiers such as EZH2 can abolish Barr body formation or maintenance, providing direct evidence of their essential roles. Knockout cell lines are valuable for studying the consequences of Barr body loss.
Point Mutation
Introducing point mutations in genes like SMCHD1 or ATRX can mimic disease-associated variants and reveal their impact on Barr body structure and function. Such models are useful for dissecting molecular mechanisms.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into genes encoding nuclear lamina proteins allows real-time visualization of Barr body positioning. Knock-in of disease mutations can also model human disorders.
Overexpression
Overexpression of XIST in male cells can induce Barr body-like structures, enabling study of X-inactivation in a non-native context. Overexpression of silencing factors can also perturb heterochromatin.
How EDITGENE Supports Barr body Research
Researchers studying Barr body-related genes often need to determine whether a candidate gene is causally involved in X-chromosome inactivation, heterochromatin maintenance, or cancer progression. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models, enabling functional validation of genes associated with GO:0001740.
Contact EDITGENE today to design your custom CRISPR model for Barr body research.
Frequently Asked Questions About Barr body
What is a Barr body?
A Barr body is a densely heterochromatic, silenced X chromosome found in female mammalian cells, typically located at the nuclear periphery.
What genes are involved in Barr body formation?
Key genes include XIST, EZH2, SUZ12, EED, RNF2, SMCHD1, and others involved in X-chromosome inactivation.
What is the function of the Barr body?
It serves as a mechanism for dosage compensation, ensuring that XX females and XY males express similar levels of X-linked genes.
How is the Barr body detected?
It can be detected by simple staining (e.g., Giemsa) in interphase nuclei, or by RNA FISH for XIST RNA.
Is the Barr body present in males?
No, the Barr body is typically absent in normal male cells because they have only one X chromosome.
What diseases are associated with Barr body loss?
Loss of the Barr body has been observed in breast, ovarian, and head and neck cancers.
Can CRISPR be used to study the Barr body?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to study genes controlling Barr body formation and maintenance.
What is XIST and how does it relate to the Barr body?
XIST is a long non-coding RNA that coats the inactive X chromosome and initiates the silencing process that leads to the Barr body.
Why is the Barr body important in cancer?
Disruption of the Barr body and heterochromatin instability are linked to cancer progression and may serve as diagnostic markers.
How can I create a Barr body research model?
EDITGENE offers custom CRISPR services including knockout, point mutation, knock-in, and overexpression to generate relevant cell models.
Conclusion
The Barr body (GO:0001740) is a cornerstone of epigenetic regulation and nuclear organization, with critical roles in dosage compensation and disease. Its study continues to reveal fundamental mechanisms of gene silencing and heterochromatin formation. Leveraging advanced CRISPR technologies, researchers can now dissect the genetic and epigenetic networks controlling the Barr body, opening new avenues for therapeutic intervention in cancer and other diseases.
References
- 1. Sharma D et al.. 2017. Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.. Sultan Qaboos Univ Med J 17(4):e389-e397 PMID: 29372079
- 2. Dixon-McDougall T et al.. 2016. The making of a Barr body: the mosaic of factors that eXIST on the mammalian inactive X chromosome.. Biochem Cell Biol 94(1):56-70 PMID: 26283003
- 3. Pageau GJ et al.. 2007. The disappearing Barr body in breast and ovarian cancers.. Nat Rev Cancer 7(8):628-33 PMID: 17611545
- 4. Ghosh SN et al.. 1981. Significance of the Barr body in human female tumors.. Cancer Genet Cytogenet 4(3):269-74 PMID: 7032686
- 5. Carone DM et al.. 2013. Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.. Semin Cancer Biol 23(2):99-108 PMID: 22722067
- 6. Agrawal P et al.. 2012. Barr body in fine needle aspiration cytology of ovarian malignancies.. Diagn Cytopathol 40(11):964-6 PMID: 21416650
- 7. DAVIDSON RG. 1964. THE LYON HYPOTHESIS.. J Pediatr 65:765-75 PMID: 14221179
- 8. Engel E et al.. 1970. Barr body studies from the hair.. Lancet 1(7650):789 PMID: 4191300
